Scientists turn human stomach cells into insulin-producing beta cells
Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas…
Discovery of vascular-associated fibroblastic cells opens new path for diabetes treatment
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce…
SMOC1 gene plays a surprising role in the development of type 2 diabetes
Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in…
Oral microbiome linked to threefold higher pancreatic cancer risk
Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied…
New genetic test redefines diagnosis and management of hereditary pancreatitis
A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis. Pancreatitis, inflammation…
Fucosylation emerges as a key player in digestive inflammatory diseases and cancers
Fucosylation, a crucial post-translational modification, has emerged as a significant factor influencing digestive inflammatory diseases and cancers. This…
Leptin could offer alternative to insulin for managing type 1 diabetes complication
More than a decade ago, researchers found that an acute complication of type 1 diabetes, diabetic ketoacidosis (DKA),…